secwatch.observer — SEC 8-K summary
======================================

Issuer:     XBiotech Inc. (XBIT)
CIK:        0001626878
Form:       8-K
Filed at:   2025-10-03T23:59:59+00:00
Accession:  0001171843-25-006266
Event type: other
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XBiotech enters new employment agreement with CEO John Simard; $1.25M salary, $4.53M bonus baseline
--------------------------------------------------------------------------------

- Base salary unchanged at $1.25M; annual bonus baseline set at $4.53M for 2025, both inflation-adjusted annually.
- Severance: 3 years base salary + 3 years base bonus if terminated without cause, disability, or retirement; 80% if for cause.
- Upon retirement, CEO to consult for 18 months receiving additional base salary payments plus severance.
- Agreement formalizes compensation trends over past 5 years; approved by Compensation Committee of independent directors.
- Executive remains CEO and President; no change in leadership roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626878/000117184325006266/0001171843-25-006266-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626878/000117184325006266/f8k_100325.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-006266

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer